BARTOLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 927
EU - Europa 882
AS - Asia 256
AF - Africa 9
OC - Oceania 1
SA - Sud America 1
Totale 2.076
Nazione #
US - Stati Uniti d'America 925
RU - Federazione Russa 348
IT - Italia 186
PL - Polonia 150
CN - Cina 93
SE - Svezia 76
HK - Hong Kong 66
IE - Irlanda 61
SG - Singapore 58
CH - Svizzera 15
FI - Finlandia 14
DE - Germania 13
IN - India 13
CI - Costa d'Avorio 8
TR - Turchia 8
UA - Ucraina 6
VN - Vietnam 6
GB - Regno Unito 5
JO - Giordania 5
KR - Corea 4
NL - Olanda 4
CA - Canada 2
ES - Italia 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
GE - Georgia 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
SC - Seychelles 1
Totale 2.076
Città #
Santa Clara 247
Warsaw 150
Chandler 83
Fairfield 75
Dublin 61
Ashburn 59
Singapore 47
Hong Kong 46
Woodbridge 41
Wilmington 31
Houston 30
Cambridge 29
Seattle 29
Beijing 28
Florence 26
Princeton 20
Shanghai 20
Moscow 19
Altamura 16
Rome 16
Bern 15
Buffalo 15
Lawrence 15
Boston 13
Milan 13
Jacksonville 12
Ann Arbor 11
Mumbai 11
Naples 10
Kent 9
Abidjan 8
Boardman 8
Bologna 7
Medford 6
Pisa 6
Andover 5
Catania 5
Izmir 5
New York 5
Turin 5
Cagliari 4
Dong Ket 4
Seoul 4
Trento 4
West Jordan 4
Yubileyny 4
Los Angeles 3
Ankara 2
Barcelona 2
Bari 2
Baselga di Pinè 2
Caserta 2
Cohasset 2
Falls Church 2
Guangzhou 2
Helsinki 2
Hillsboro 2
Hilversum 2
Ho Chi Minh City 2
Iesi 2
Indianapolis 2
Lissone 2
Macherio 2
Mariano Comense 2
Modena 2
Munich 2
Nanjing 2
Norwalk 2
Pune 2
Saint Paul 2
San Diego 2
Sant'Anastasia 2
Sassari 2
Selargius 2
Shijiazhuang 2
Arona 1
Atlanta 1
Auburn Hills 1
Bucharest 1
Calamba 1
Carpi 1
Chicago 1
Karachi 1
Kilburn 1
Kunming 1
London 1
Messina 1
Miami Beach 1
Montevarchi 1
Montreal 1
Nuremberg 1
Salerno 1
San Mateo 1
San Pietro di Feletto 1
Shenyang 1
Sydney 1
Toronto 1
Verona 1
Washington 1
Xuzhou 1
Totale 1.365
Nome #
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 229
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 169
Calcinosis in systemic sclerosis: subsets, distribution and complications 125
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). 120
The safety of iloprost in systemic sclerosis in a real-life experience 114
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study. 113
Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. 109
Transitional connective tissue diseases: description of four cases 109
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 99
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 82
Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides 78
Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). 76
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 76
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 74
FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists 68
Treatment of ulcers in systemic sclerosis 63
Ultrasound detects occult entheseal involvement in early psoriatic arthritis independently of clinical features and psoriasis severity. 61
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 58
Persistence of remission after lengthening of golimumab in inflammatory joint diseases 56
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 56
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 54
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 52
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus 31
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 31
Totale 2.103
Categoria #
all - tutte 6.010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.010


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020157 0 0 0 0 21 21 19 26 19 27 17 7
2020/2021137 11 6 10 22 10 16 5 8 12 14 12 11
2021/2022100 3 8 4 2 10 5 1 10 4 2 20 31
2022/2023319 33 64 15 26 14 52 39 11 29 5 13 18
2023/2024318 12 25 31 13 18 46 18 67 12 41 27 8
2024/2025831 51 130 78 251 321 0 0 0 0 0 0 0
Totale 2.103